Leegwater E - Search Results

1

Drug-drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment.

Wortman JM, Leegwater E, Van Lammeren-Venema D, Van Nieuwkoop C, Sobels A, Wilms EB. Wortman JM, et al. Among authors: leegwater e. J Antimicrob Chemother. 2023 Jun 1;78(6):1471-1475. doi: 10.1093/jac/dkad107. J Antimicrob Chemother. 2023. PMID: 37039028

2

Population pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients.

Leegwater E, Kraaijenbrink BVC, Moes DJAR, Purmer IM, Wilms EB. Leegwater E, et al. J Antimicrob Chemother. 2020 Jun 1;75(6):1554-1558. doi: 10.1093/jac/dkaa067. J Antimicrob Chemother. 2020. PMID: 32129853

3

Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors.

Leegwater E, Strik A, Wilms EB, Bosma LBE, Burger DM, Ottens TH, van Nieuwkoop C. Leegwater E, et al. Clin Infect Dis. 2021 Apr 8;72(7):1256-1258. doi: 10.1093/cid/ciaa883. Clin Infect Dis. 2021. PMID: 32594120 Free PMC article.

4

Evaluating imipenem + cilastatin + relebactam for the treatment of complicated urinary tract infections.

Kuiper SG, Leegwater E, Wilms EB, van Nieuwkoop C. Kuiper SG, et al. Among authors: leegwater e. Expert Opin Pharmacother. 2020 Oct;21(15):1805-1811. doi: 10.1080/14656566.2020.1790525. Epub 2020 Aug 21. Expert Opin Pharmacother. 2020. PMID: 32820669 Review.

5

Ceftriaxone for the Treatment of Chronic Bacterial Prostatitis: A Case Series and Literature Review.

Kuiper SG, Ploeger M, Wilms EB, van Dijk MM, Leegwater E, Huis In't Veld RAG, van Nieuwkoop C. Kuiper SG, et al. Among authors: leegwater e. Antibiotics (Basel). 2022 Jan 11;11(1):83. doi: 10.3390/antibiotics11010083. Antibiotics (Basel). 2022. PMID: 35052960 Free PMC article.

6

Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factors.

Leegwater E, Westgeest AC, Schippers EF, Wilms EB, van Nieuwkoop C, Visser LE. Leegwater E, et al. Br J Clin Pharmacol. 2022 Jun;88(6):2938-2945. doi: 10.1111/bcp.15236. Epub 2022 Feb 3. Br J Clin Pharmacol. 2022. PMID: 35060153 Free article.

7

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients.

Leegwater E, Moes DJAR, Bosma LBE, Ottens TH, van der Meer IM, van Nieuwkoop C, Wilms EB. Leegwater E, et al. Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0025422. doi: 10.1128/aac.00254-22. Epub 2022 Jun 1. Antimicrob Agents Chemother. 2022. PMID: 35647646 Free PMC article.

8

[Intoxications with synthetic cannabinoids].

Zanen JG, Leegwater E, Schippers EF, Wilms EB. Zanen JG, et al. Among authors: leegwater e. Ned Tijdschr Geneeskd. 2023 Feb 8;166:D7145. Ned Tijdschr Geneeskd. 2023. PMID: 36752668 Dutch.

9

[Intoxications with synthetic cannabinoids].

Zanen JG, Leegwater E, Schippers EF, Wilms EB. Zanen JG, et al. Among authors: leegwater e. Ned Tijdschr Geneeskd. 2023 Mar 16;167:D7145. Ned Tijdschr Geneeskd. 2023. PMID: 36943159 Dutch.

10

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.

Leegwater E, Dol L, Benard MR, Roelofsen EE, Delfos NM, van der Feltz M, Mollema FPN, Bosma LBE, Visser LE, Ottens TH, van Burgel ND, Arbous SM, El Bouazzaoui LH, Knevel R, Groenwold RHH, de Boer MGJ, Visser LG, Rosendaal FR, Wilms EB, van Nieuwkoop C. Leegwater E, et al. Infect Dis Ther. 2023 Oct;12(10):2471-2484. doi: 10.1007/s40121-023-00874-2. Epub 2023 Oct 6. Infect Dis Ther. 2023. PMID: 37801280 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page